Immune checkpoint inhibitors do not exacerbate asthma in patients with cancer

Patients with cancer undergoing treatment with immune checkpoint inhibitors did not experience exacerbations in their asthma, according to a study published in Annals of Allergy, Asthma & Immunology.
“Immune checkpoint inhibitors commonly cause allergic skin reactions,” Donald Y.M. Leung, MD, PhD, division head of pediatric allergy and clinical immunology at National Jewish Health, Denver, told Healio.
“Since asthma is a common problem and commonly causes hospitalization and emergency room visits, we wanted to know whether immune checkpoint inhibitors had an effect on asthma,”

Patients with cancer undergoing treatment with immune checkpoint inhibitors did not experience exacerbations in their asthma, according to a study published in Annals of Allergy, Asthma & Immunology.
“Immune checkpoint inhibitors commonly cause allergic skin reactions,” Donald Y.M. Leung, MD, PhD, division head of pediatric allergy and clinical immunology at National Jewish Health, Denver, told Healio.
“Since asthma is a common problem and commonly causes hospitalization and emergency room visits, we wanted to know whether immune checkpoint inhibitors had an effect on asthma,”